secwatch.observer — SEC 8-K summary
======================================

Issuer:     MCKESSON CORP (MCK)
CIK:        0000927653
Form:       8-K
Filed at:   2025-05-30T23:59:59+00:00
Accession:  0001628280-25-028495
Event type: m_and_a
Sentiment:  positive
Materiality: 0.75
Item codes: 2.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

McKesson issues $2B notes to fund acquisition of 70% stake in Community Oncology Revitalization
--------------------------------------------------------------------------------

- Issued $650M 4.650% notes due 2030, $650M 4.950% notes due 2032, $700M 5.250% notes due 2035.
- Net proceeds ~$1.99B; combined with cash on hand to fund acquisition of 70% controlling interest in Community Oncology Revitalization Enterprise Ventures (Florida Cancer Specialists).
- Interest payable semi-annually on May 30 and Nov 30, starting Nov 30, 2025.
- Notes are unsecured, unsubordinated, rank equally with existing unsecured debt; change of control/rating downgrade triggers repurchase offer at 101% plus accrued interest.
- Underwriters include Barclays, BofA Securities, Deutsche Bank, J.P. Morgan.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/927653/000162828025028495/0001628280-25-028495-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/927653/000162828025028495/mck-20250520.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-028495

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer